These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 28493438)
1. Deficient activity of alanyl-tRNA synthetase underlies an autosomal recessive syndrome of progressive microcephaly, hypomyelination, and epileptic encephalopathy. Nakayama T; Wu J; Galvin-Parton P; Weiss J; Andriola MR; Hill RS; Vaughan DJ; El-Quessny M; Barry BJ; Partlow JN; Barkovich AJ; Ling J; Mochida GH Hum Mutat; 2017 Oct; 38(10):1348-1354. PubMed ID: 28493438 [TBL] [Abstract][Full Text] [Related]
2. Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect. Simons C; Griffin LB; Helman G; Golas G; Pizzino A; Bloom M; Murphy JL; Crawford J; Evans SH; Topper S; Whitehead MT; Schreiber JM; Chapman KA; Tifft C; Lu KB; Gamper H; Shigematsu M; Taft RJ; Antonellis A; Hou YM; Vanderver A Am J Hum Genet; 2015 Apr; 96(4):675-81. PubMed ID: 25817015 [TBL] [Abstract][Full Text] [Related]
3. A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N). McLaughlin HM; Sakaguchi R; Giblin W; ; Wilson TE; Biesecker L; Lupski JR; Talbot K; Vance JM; Züchner S; Lee YC; Kennerson M; Hou YM; Nicholson G; Antonellis A Hum Mutat; 2012 Jan; 33(1):244-53. PubMed ID: 22009580 [TBL] [Abstract][Full Text] [Related]
4. Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities. Weterman MAJ; Kuo M; Kenter SB; Gordillo S; Karjosukarso DW; Takase R; Bronk M; Oprescu S; van Ruissen F; Witteveen RJW; Bienfait HME; Breuning M; Verhamme C; Hou YM; de Visser M; Antonellis A; Baas F Hum Mol Genet; 2018 Dec; 27(23):4036-4050. PubMed ID: 30124830 [TBL] [Abstract][Full Text] [Related]
5. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Latour P; Thauvin-Robinet C; Baudelet-Méry C; Soichot P; Cusin V; Faivre L; Locatelli MC; Mayençon M; Sarcey A; Broussolle E; Camu W; David A; Rousson R Am J Hum Genet; 2010 Jan; 86(1):77-82. PubMed ID: 20045102 [TBL] [Abstract][Full Text] [Related]
6. WARS1 and SARS1: Two tRNA synthetases implicated in autosomal recessive microcephaly. Bögershausen N; Krawczyk HE; Jamra RA; Lin SJ; Yigit G; Hüning I; Polo AM; Vona B; Huang K; Schmidt J; Altmüller J; Luppe J; Platzer K; Dörgeloh BB; Busche A; Biskup S; Mendes MI; Smith DEC; Salomons GS; Zibat A; Bültmann E; Nürnberg P; Spielmann M; Lemke JR; Li Y; Zenker M; Varshney GK; Hillen HS; Kratz CP; Wollnik B Hum Mutat; 2022 Oct; 43(10):1454-1471. PubMed ID: 35790048 [TBL] [Abstract][Full Text] [Related]
7. CMT disease severity correlates with mutation-induced open conformation of histidyl-tRNA synthetase, not aminoacylation loss, in patient cells. Blocquel D; Sun L; Matuszek Z; Li S; Weber T; Kuhle B; Kooi G; Wei N; Baets J; Pan T; Schimmel P; Yang XL Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19440-19448. PubMed ID: 31501329 [TBL] [Abstract][Full Text] [Related]
8. Neurodegenerative Charcot-Marie-Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases. Wei N; Zhang Q; Yang XL J Biol Chem; 2019 Apr; 294(14):5321-5339. PubMed ID: 30643024 [TBL] [Abstract][Full Text] [Related]
9. Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures. Zhang X; Ling J; Barcia G; Jing L; Wu J; Barry BJ; Mochida GH; Hill RS; Weimer JM; Stein Q; Poduri A; Partlow JN; Ville D; Dulac O; Yu TW; Lam AT; Servattalab S; Rodriguez J; Boddaert N; Munnich A; Colleaux L; Zon LI; Söll D; Walsh CA; Nabbout R Am J Hum Genet; 2014 Apr; 94(4):547-58. PubMed ID: 24656866 [TBL] [Abstract][Full Text] [Related]
10. CMT2N-causing aminoacylation domain mutants enable Nrp1 interaction with AlaRS. Sun L; Wei N; Kuhle B; Blocquel D; Novick S; Matuszek Z; Zhou H; He W; Zhang J; Weber T; Horvath R; Latour P; Pan T; Schimmel P; Griffin PR; Yang XL Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753480 [TBL] [Abstract][Full Text] [Related]
11. Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy. Stephen J; Nampoothiri S; Banerjee A; Tolman NJ; Penninger JM; Elling U; Agu CA; Burke JD; Devadathan K; Kannan R; Huang Y; Steinbach PJ; Martinis SA; Gahl WA; Malicdan MCV Hum Genet; 2018 Apr; 137(4):293-303. PubMed ID: 29691655 [TBL] [Abstract][Full Text] [Related]
12. Mutations in the glutaminyl-tRNA synthetase gene cause early-onset epileptic encephalopathy. Kodera H; Osaka H; Iai M; Aida N; Yamashita A; Tsurusaki Y; Nakashima M; Miyake N; Saitsu H; Matsumoto N J Hum Genet; 2015 Feb; 60(2):97-101. PubMed ID: 25471517 [TBL] [Abstract][Full Text] [Related]
13. A novel AARS mutation in a family with dominant myeloneuropathy. Motley WW; Griffin LB; Mademan I; Baets J; De Vriendt E; De Jonghe P; Antonellis A; Jordanova A; Scherer SS Neurology; 2015 May; 84(20):2040-7. PubMed ID: 25904691 [TBL] [Abstract][Full Text] [Related]
14. Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails. Kuo ME; Theil AF; Kievit A; Malicdan MC; Introne WJ; Christian T; Verheijen FW; Smith DEC; Mendes MI; Hussaarts-Odijk L; van der Meijden E; van Slegtenhorst M; Wilke M; Vermeulen W; Raams A; Groden C; Shimada S; Meyer-Schuman R; Hou YM; Gahl WA; Antonellis A; Salomons GS; Mancini GMS Am J Hum Genet; 2019 Mar; 104(3):520-529. PubMed ID: 30824121 [TBL] [Abstract][Full Text] [Related]
15. Alanyl-tRNA synthetase 1 (AARS1) gene mutation in a family with intermediate Charcot-Marie-Tooth neuropathy. Lee AJ; Nam DE; Choi YJ; Nam SH; Choi BO; Chung KW Genes Genomics; 2020 Jun; 42(6):663-672. PubMed ID: 32314272 [TBL] [Abstract][Full Text] [Related]
16. Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients. Cassandrini D; Cilio MR; Bianchi M; Doimo M; Balestri M; Tessa A; Rizza T; Sartori G; Meschini MC; Nesti C; Tozzi G; Petruzzella V; Piemonte F; Bisceglia L; Bruno C; Dionisi-Vici C; D'Amico A; Fattori F; Carrozzo R; Salviati L; Santorelli FM; Bertini E J Inherit Metab Dis; 2013 Jan; 36(1):43-53. PubMed ID: 22569581 [TBL] [Abstract][Full Text] [Related]
17. Coordination between aminoacylation and editing to protect against proteotoxicity. Zhang H; Murphy P; Yu J; Lee S; Tsai FTF; van Hoof A; Ling J Nucleic Acids Res; 2023 Oct; 51(19):10606-10618. PubMed ID: 37742077 [TBL] [Abstract][Full Text] [Related]
18. Biallelic mutations in valyl-tRNA synthetase gene VARS are associated with a progressive neurodevelopmental epileptic encephalopathy. Friedman J; Smith DE; Issa MY; Stanley V; Wang R; Mendes MI; Wright MS; Wigby K; Hildreth A; Crawford JR; Koehler AE; Chowdhury S; Nahas S; Zhai L; Xu Z; Lo WS; James KN; Musaev D; Accogli A; Guerrero K; Tran LT; Omar TEI; Ben-Omran T; Dimmock D; Kingsmore SF; Salomons GS; Zaki MS; Bernard G; Gleeson JG Nat Commun; 2019 Feb; 10(1):707. PubMed ID: 30755602 [TBL] [Abstract][Full Text] [Related]